Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07187908
What this trial is testing

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Who this might be right for
Primary/Secondary PreventionHigh Risk for Febrile Neutropenia of Chemotherapy RegimensIntermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Henan Cancer Hospital 1,076
Testing effectiveness (Phase 2)UnknownNCT02077335
What this trial is testing

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CSSS de Gatineau 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01318317
What this trial is testing

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+2 more
City of Hope Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00407264
What this trial is testing

Randomized Trial of Fluticasone in Bronchial Premalignancy

Who this might be right for
Bronchogenic Carcinoma
Amsterdam UMC, location VUmc 90
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Not applicableLooking for participantsNCT07792993
What this trial is testing

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Who this might be right for
Localized Prostate Cancer
Regina Elena Cancer Institute 82
Large-scale testing (Phase 3)Study completedNCT00833248
What this trial is testing

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 246
Early research (Phase 1)Ended earlyNCT01003678
What this trial is testing

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

Who this might be right for
Myelodysplastic Syndrome
Roswell Park Cancer Institute 4
Not applicableUnknownNCT05990985
What this trial is testing

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Hospital of Jilin University 20
Testing effectiveness (Phase 2)Study completedNCT02397408
What this trial is testing

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 18
Not applicableNot Yet RecruitingNCT07724886
What this trial is testing

Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

Who this might be right for
Bladder Cancer
Chinese University of Hong Kong 732
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Testing effectiveness (Phase 2)Looking for participantsNCT05704829
What this trial is testing

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

Who this might be right for
HER2-positive Early Breast Cancer
Women's Cancer Study Group GmbH 702
Not applicableStudy completedNCT05217186
What this trial is testing

Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements

Who this might be right for
Cerebral PalsyInfant, Premature, DiseasesInfant Development+6 more
Kahramanmaras Sutcu Imam University 63
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Not applicableStudy completedNCT07345234
What this trial is testing

Comparison Between Supine Mini-PCNL and Flexible Ureteroscopy (FURS) for Dense Lower Calyceal Stones (1-2 cm) in School-Age Pediatric Patients

Who this might be right for
NephrolithiasisKidney CalculiUrolithiasis
Ain Shams University 180
Not applicableUnknownNCT03855436
What this trial is testing

Risk Factors of Intermediate Coronary Lesion Progression

Who this might be right for
Coronary AtherosclerosesCoronary Angiography
China National Center for Cardiovascular Diseases 1,389
Testing effectiveness (Phase 2)Active Not RecruitingNCT07047001
What this trial is testing

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Adjuvant
Dong Wen 60
Not applicableStudy completedNCT01836536
What this trial is testing

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients

Who this might be right for
GlioblastomaGlioma
Center Eugene Marquis 30
Early research (Phase 1)Active Not RecruitingNCT02051257
What this trial is testing

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 51
Next Page